ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Cancer Mmeetings Lister For Next Three Months

February 23, 1996

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Gore, Agency Report, Support Legislation To Protect Genetic Info

January 30, 1998

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

In Brief: Olden Chosen To Head NIEHS; Cancer Panel To Discuss Cancer and Poverty On July 9

June 28, 1991